Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosus	Not yet recruiting	Phase 1	2026-02-13		NCT07408908

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking Union Medical College Hospital	417
Xiamen Amoytop Biotech Co., Ltd.	11

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials